Form 4: 10x Genomics CEO Serge Saxonov Reports Stock Disposal
SEC Filing Form 4
Serge Saxonov, CEO of 10x Genomics, reported the disposal of 425 shares of Class A Common Stock on May 29, 2024.
Summary
- Serge Saxonov, the CEO of 10x Genomics, filed a Form 4 with the SEC.
- The filing reports a transaction on May 29, 2024, where 425 shares of Class A Common Stock were disposed of at a price of $0.
- Following the transaction, Saxonov directly owns 889,216 shares.
- Saxonov also indirectly owns shares through several trusts: Andromeda Trust (27 shares), Sirius Trust (870 shares), Y/S Descendants' Trust (213,250 shares), and Y/S Pot Trust (22,570 shares).
Sentiment
Score: 5
Explanation: This is a routine filing related to stock transactions by an insider. The sentiment is neutral as it doesn't inherently indicate positive or negative news about the company's performance.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates changes in Serge Saxonov's ownership of 10x Genomics stock.
Stakeholder Impact
- The transaction may have a minor impact on shareholders as it reflects a change in the CEO's holdings.
Key Dates
| Date | Description |
|---|---|
| 05/29/2024 | Date of stock disposal transaction |
| 05/31/2024 | Date of Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.